Ameriprise’s Inogen INGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.31M | Sell |
859,543
-1,006
| -0.1% | -$6.21K | ﹤0.01% | 2391 |
|
|
2025
Q4 | $5.78M | Buy |
860,549
+7,822
| +0.9% | +$58.7K | ﹤0.01% | 2338 |
|
|
2025
Q3 | $6.97M | Sell |
852,727
-28,373
| -3% | -$212K | ﹤0.01% | 2171 |
|
|
2025
Q2 | $6.19M | Buy |
881,100
+6,573
| +0.8% | +$44.2K | ﹤0.01% | 2199 |
|
|
2025
Q1 | $6.24M | Buy |
874,527
+25,547
| +3% | +$241K | ﹤0.01% | 2139 |
|
|
2024
Q4 | $7.79M | Buy |
848,980
+5,148
| +0.6% | +$48.1K | ﹤0.01% | 2003 |
|
|
2024
Q3 | $8.19M | Buy |
843,832
+12,542
| +2% | +$132K | ﹤0.01% | 1977 |
|
|
2024
Q2 | $6.76M | Sell |
831,290
-16,252
| -2% | -$126K | ﹤0.01% | 2068 |
|
|
2024
Q1 | $6.84M | Sell |
847,542
-112,017
| -12% | -$793K | ﹤0.01% | 2120 |
|
|
2023
Q4 | $5.27M | Buy |
959,559
+287,993
| +43% | +$1.52M | ﹤0.01% | 2305 |
|
|
2023
Q3 | $3.51M | Buy |
671,566
+317,096
| +89% | +$2.25M | ﹤0.01% | 2539 |
|
|
2023
Q2 | $4.09M | Buy |
354,470
+227,549
| +179% | +$2.68M | ﹤0.01% | 2485 |
|
|
2023
Q1 | $1.58M | Sell |
126,921
-336,663
| -73% | -$6.45M | ﹤0.01% | 2940 |
|
|
2022
Q4 | $9.14M | Buy |
463,584
+49,571
| +12% | +$1.07M | ﹤0.01% | 1806 |
|
|
2022
Q3 | $10.1M | Buy |
414,013
+13,361
| +3% | +$369K | ﹤0.01% | 1673 |
|
|
2022
Q2 | $9.69M | Buy |
400,652
+22,804
| +6% | +$606K | ﹤0.01% | 1770 |
|
|
2022
Q1 | $12.2M | Sell |
377,848
-54,536
| -13% | -$1.71M | ﹤0.01% | 1747 |
|
|
2021
Q4 | $14.7M | Buy |
432,384
+128,711
| +42% | +$4.68M | ﹤0.01% | 1650 |
|
|
2021
Q3 | $13.1M | Buy |
303,673
+16,347
| +6% | +$1.01M | ﹤0.01% | 1628 |
|
|
2021
Q2 | $18.7M | Sell |
287,326
-34,747
| -11% | -$2.2M | 0.01% | 1406 |
|
|
2021
Q1 | $16.9M | Buy |
322,073
+15,302
| +5% | +$764K | 0.01% | 1461 |
|
|
2020
Q4 | $13.7M | Sell |
306,771
-51,474
| -14% | -$1.78M | ﹤0.01% | 1509 |
|
|
2020
Q3 | $10.4M | Buy |
358,245
+70,853
| +25% | +$2.23M | ﹤0.01% | 1532 |
|
|
2020
Q2 | $10.2M | Buy |
287,392
+124,445
| +76% | +$5.24M | ﹤0.01% | 1528 |
|
|
2020
Q1 | $8.42M | Buy |
162,947
+61,126
| +60% | +$2.94M | ﹤0.01% | 1515 |
|
|
2019
Q4 | $6.96M | Sell |
101,821
-1,901
| -2% | -$119K | ﹤0.01% | 2018 |
|
|
2019
Q3 | $4.97M | Buy |
103,722
+42,439
| +69% | +$2.21M | ﹤0.01% | 2208 |
|
|
2019
Q2 | $4.09M | Sell |
61,283
-4,303
| -7% | -$328K | ﹤0.01% | 2360 |
|
|
2019
Q1 | $6.26M | Sell |
65,586
-97,135
| -60% | -$12.1M | ﹤0.01% | 2077 |
|
|
2018
Q4 | $20.2M | Sell |
162,721
-20,751
| -11% | -$3.42M | 0.01% | 1052 |
|
|
2018
Q3 | $44.8M | Sell |
183,472
-38,303
| -17% | -$8.86M | 0.02% | 806 |
|
|
2018
Q2 | $41.3M | Sell |
221,775
-23,957
| -10% | -$3.99M | 0.02% | 759 |
|
|
2018
Q1 | $30.2M | Buy |
245,732
+84,797
| +53% | +$10.4M | 0.01% | 908 |
|
|
2017
Q4 | $19.2M | Sell |
160,935
-26,133
| -14% | -$2.88M | 0.01% | 1098 |
|
|
2017
Q3 | $17.8M | Buy |
187,068
+10,669
| +6% | +$1.03M | 0.01% | 1133 |
|
|
2017
Q2 | $16.8M | Buy |
176,399
+48,414
| +38% | +$4.14M | 0.01% | 1156 |
|
|
2017
Q1 | $9.93M | Buy |
127,985
+11,223
| +10% | +$778K | 0.01% | 1523 |
|
|
2016
Q4 | $7.84M | Sell |
116,762
-24,258
| -17% | -$1.5M | ﹤0.01% | 1692 |
|
|
2016
Q3 | $8.45M | Sell |
141,020
-4,175
| -3% | -$233K | ﹤0.01% | 1595 |
|
|
2016
Q2 | $7.28M | Buy |
145,195
+9,215
| +7% | +$439K | ﹤0.01% | 1656 |
|
|
2016
Q1 | $6.12M | Buy |
135,980
+4,825
| +4% | +$172K | ﹤0.01% | 1801 |
|
|
2015
Q4 | $5.26M | Buy |
131,155
+43,835
| +50% | +$1.85M | ﹤0.01% | 1983 |
|
|
2015
Q3 | $4.24M | Buy |
+87,320
| New | +$4.15M | ﹤0.01% | 2129 |
|
Other funds holding INGN
AC
VCM
DCM
Ameriprise's INGN Position: Q1 2026 in Review
Ameriprise reduced its Inogen (INGN) stake by 0.12% in Q1 2026, selling an estimated $6.21K and leaving 859,543 shares worth $5.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2391.
Ameriprise first reported a position in INGN in Q3 2015 and has held it in 43 quarters since. The position peaked at $44.8M in Q3 2018. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.
- Ameriprise held 859,543 shares of Inogen worth $5.31M as of Q1 2026.
- Ameriprise sold 1,006 Inogen shares in Q1 2026, an estimated $6.21K.
- Inogen made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2391 holding.
- Ameriprise first reported a position in Inogen in Q3 2015 and has held it in 43 quarters since.
- Ameriprise's Inogen position peaked at $44.8M in Q3 2018.
- 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.